Rui You

52 Meihua East Road
Zhuhai, 519000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 78 publications

A Surgical Map Defining High-Risk Anatomical Boundaries for Salvage Endoscopic Nasopharyngectomy.

A Surgical Map Defining High-Risk Anatomical Boundaries for Salvage Endoscopic Nasopharyngectomy.

Journal: The Laryngoscope

Published: May 21, 2026

Standard chemoradiotherapy with concurrent and adjuvant camrelizumab in patients with high risk nasopharyngeal carcinoma: multicentre, randomised, open label, phase 3 trial.

Standard chemoradiotherapy with concurrent and adjuvant camrelizumab in patients with high risk nasopharyngeal carcinoma: multicentre, randomised, open label, phase 3 trial.

Journal: BMJ (Clinical research ed.)

Published: February 10, 2026

NSUN2-mediated m5C modification of BHLF1 RNA facilitates the lytic replication of Epstein-Barr virus.

NSUN2-mediated m5C modification of BHLF1 RNA facilitates the lytic replication of Epstein-Barr virus.

Journal: Cell reports

Published: November 18, 2025

Pedicled Inferior Turbinate-Nasal Floor and Septal Mucoperiosteal Flap Resurfacing for PRNN.

Pedicled Inferior Turbinate-Nasal Floor and Septal Mucoperiosteal Flap Resurfacing for PRNN.

Journal: The Laryngoscope

Published: November 05, 2025

Efficacy of primary lesion re-irradiation in nasopharyngeal carcinoma with synchronous recurrence and distant metastasis.

Efficacy of primary lesion re-irradiation in nasopharyngeal carcinoma with synchronous recurrence and distant metastasis.

Journal: Oral oncology

Published: August 12, 2025

NAB-paclitaxel and cisplatin versus gemcitabine and cisplatin as induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: a retrospective, propensity score-matched analysis.

NAB-paclitaxel and cisplatin versus gemcitabine and cisplatin as induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: a retrospective, propensity score-matched analysis.

Journal: Therapeutic advances in medical oncology

Published: August 11, 2025

Discontinuation of immunotherapy and its effect on prognosis in recurrent or metastatic nasopharyngeal carcinoma patients: a retrospective analysis.

Discontinuation of immunotherapy and its effect on prognosis in recurrent or metastatic nasopharyngeal carcinoma patients: a retrospective analysis.

Journal: Cancer immunology, immunotherapy : CII

Published: June 16, 2025

Comparison of ≥2 lines immunotherapy regimens for recurrent/metastatic nasopharyngeal carcinoma.

Comparison of ≥2 lines immunotherapy regimens for recurrent/metastatic nasopharyngeal carcinoma.

Journal: International journal of cancer

Published: June 11, 2025

The value of nasopharyngeal brush versus plasma EBV DNA detection in diagnosing local recurrence of nasopharyngeal carcinoma.

The value of nasopharyngeal brush versus plasma EBV DNA detection in diagnosing local recurrence of nasopharyngeal carcinoma.

Journal: International journal of cancer

Published: May 22, 2025

Induction versus Concurrent Chemotherapy for Advanced Nasopharyngeal Carcinoma.

Induction versus Concurrent Chemotherapy for Advanced Nasopharyngeal Carcinoma.

Journal: NEJM evidence

Published: April 22, 2025

TQB2450 plus intensity-modulated radiotherapy in recurrent nasopharyngeal carcinoma: An open-label, single-arm, phase II trial.

TQB2450 plus intensity-modulated radiotherapy in recurrent nasopharyngeal carcinoma: An open-label, single-arm, phase II trial.

Journal: Med (New York, N.Y.)

Published: April 17, 2025

Endoscopic Transoropharyngeal Retropharyngeal Lymph Node (RPLN) Dissection for RPLN Recurrence Nasopharyngeal Carcinoma.

Endoscopic Transoropharyngeal Retropharyngeal Lymph Node (RPLN) Dissection for RPLN Recurrence Nasopharyngeal Carcinoma.

Journal: Annals of surgical oncology

Published: January 20, 2025

Showing 1-12 of 78

Last Updated: 09/26/2026